ApprovalTrail

Approval · Notice of Compliance 5580 · 1994

DIXARIT: Notice of Compliance 5580

Issued December 15, 1994

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5580
Date
December 15, 1994
Company
Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Revised product monograph
Therapeutic class
Vascular stabilizer for the treatment of menopausal flushing

Products in this notice

BrandDINStatus today
DIXARITNot yet assigned—

Medicinal ingredients